News
Krebs erfolgreich geheilt - Klinische Studie mit sensationellen Ergebnissen. Massives Kaufsignal. Neuer 202% Biotech Hot Stock nach 3.296% mit BioNTech ($BNTX), 10.996% mit Pfizer ($PFE), 31.205% mit Amgen ($AMG) und 134.452% mit Biogen ($BIIB).
Krebs erfolgreich geheilt - Klinische Studie mit sensation. Ergebnissen. 202% Biotech Hot Stock nach 134.452% mit Biogen
24.07.23 08:02
London (www.aktiencheck.de , Anzeige)
Winners And Losers In The Oilfield Supercycle
There are no losers in the oil field super cycle, only winners, but winning is relative. While the signs are good that the spending in upstream, natural gas, and efficiency will continue, 1
Did CSX Corporation’s Rebound Just Go Off The Rails?
CSX Corporation (NASDAQ: CSX) stock has been trying hard to get off a technical bottom, and the recovery might have gone off the rails. The Q2 results were less than expected and caused shares
IBM Is The Perfect Example Of Why Size Matters: An Earnings Story
International Business Machines (NYSE: IBM) share rose by as much as 3.0% to mark the high for Thursday's trading session. The reaction came from the company's second quarter 2023 earnings
2 Fintech Stocks to Buy Now and 1 to Avoid
Youth will be served. That’s how I would explain the speed and pervasiveness with which financial technology (fintech) has disrupted the financial sector. Millennial and Gen-Z investors have grown
Biotech Hot Stock meldet großartige Studienergebnisse - Massives Kaufsignal. Neuer 202% Biotech Hot Stock nach 3.296% mit BioNTech ($BNTX), 10.996% mit Pfizer ($PFE), 31.205% mit Amgen ($AMG) und 134.452% mit Biogen ($BIIB).
Biotech Hot Stock meldet großartige Studienergebnisse - Kaufsignal. 202% Biotech Aktientip nach 10996% mit Pfizer ($PFE)
21.07.23 08:02
London (www.aktiencheck.de , Anzeige)
American Airlines Beats Earnings, Thinking Of Buying?
Airline giant American Airlines Group (NASDAQ: AAL) reported second-quarter 2023 earnings results. The stock is trading down 6% in early trading as investors digest the report, perhaps providing
3 Undervalued Large-Cap Stocks That Won't Be for Long
The market rally is starting to extend beyond the “Magnificent 7” tech stocks. Yet many analysts and economists still believe investors may be in for a nasty pullback before the year ends.
Market
Abbott Laboratories Has the Prescription for Higher Share Prices
Abbott Laboratories (NYSE: ABT) is a tale of two stories. The first is its recovery from the COVID-19 boost and bubble. The second is the underlying core business, which is as strong as ever.
Will a Decrease in Housing Starts Hurt Homebuilder Stocks?
Homebuilders traded lower as a group on July 19, ending the session down 0.20% after the National Association of Homebuilders reported that June housing starts fell more than expected.
As a
Grid Dynamics Earns Membership in Microsoft’s Azure Migration and Modernization Program
Grid Dynamics Earns Membership in Microsoft’s Azure Migration and Modernization Program - Enabling Its Clients to Accelerate Time to Value on Cloud Transformation Initiatives and Invest in
Grid Dynamics wird Mitglied in Microsofts Azure Migration and Modernization Program
Grid Dynamics wird Mitglied in Microsofts Azure Migration and Modernization Program und ermöglicht seinen Kunden damit, den „Time-to-Value“ bei Cloud-basierten Transformationsinitiativen zu
Is This The Top For Tesla Stock?
Tesla (NASDAQ: TSLA) shares have been rocketing higher all year, and by rights, they should continue to do so. The Q2 results are a testament to Elon Musk’s dedication and leadership abilities
Hershey's Stock Dip Presents a Sweet Opportunity
In May 2023, The Hershey Company (NYSE: HSY) launched a limited edition churro-flavored Kit Kat just in time for summer. Since then, approximately 10% has been trimmed from the leading U.S
Four Reasons Why Apple Could Soar To New Highs In Q3
If you look at the chart of Apple’s (NASDAQ: AAPL) stock price and wonder if it can bob to another new high, the odds are high that it can do so. This is among the world’s most-followed
Profits Decline At Goldman Sachs, Time To Pick Up Cheap Shares?
Most investors may be disappointed that the mystical firm, The Goldman Sachs Group (NYSE: GS), a name often synonymous with the creme de la creme on Wall Street, has reported declining business
Acumen Soars on Alzheimer's Study...Street Sees It Doubling
Two years removed from an IPO, Acumen Pharmaceuticals, Inc. (NASDAQ: ABOS) looks like it made a good decision to go public. Shares of the Charlottesville, Virginia-based biotechnology company
Canoo Blasts Higher on DOD, NASA News...Is a Big Squeeze Ahead?
In what’s been a strong recovery year for electric vehicle (EV) makers, Canoo Inc. (NYSE: GOEV) has mostly gone against the tide. Last month, shares of the California-based EV longshot slipped to
ZScaler Is On The Brink Of Reversal
Among other cybersecurity stocks, ZScaler (NASDAQ: ZS) has been trying to effect a rebound and reversal all year. The industry has struggled to gain momentum, but that may be ending. It’s been
Analyst Upgrade Drives Uber To 2-Year High, Despite Court Ruling
The constant, unrelenting threat of labor-law challenges and wage increases hasn’t hurt Uber Technologies Inc.’s (NASDAQ: UBER) ride to a two-year high.
The stock is still actionable after
These Two Crypto Stocks Are Up Over 400% YTD
If you have been spending time on Twitter recently, you might have noticed increased excitement and conversation surrounding Bitcoin. That's because the popular cryptocurrency is once again
Celsius Winning Energy Drink Race, Outpacing Rival Monster
Celsius Holdings Inc. (NASDAQ: CELH) is in a potential buy zone pulling back to trend along its 21-day moving average, below a June 28 high of $153.94.
Shares were pulling back on June 28, as
Morgan Stanley Second Quarter Earnings, Time For A Breakout?
As measured by the VIX (CBOE Volatility Index), volatility in broader equity markets has compressed significantly over the past year. 2022 saw an average VIX above 25%, historically high and
Banking On Bank Of America In The 2nd Half
Results from banks like Bank of America (NYSE: BAC) and JPMorgan Chase (NYSE: JPM) suggest the Fed is getting closer to achieving its much-desired soft-landing. Bank of America’s Q2 results are
FMC Drops Below $100, Investors Cultivate Positions
Agricultural sciences leader FMC Corporation (NYSE: FMC) slashed its second quarter and full-year outlook last week, sparking a high-volume selloff. The market’s response since suggests a plowed